학술논문

Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma
Document Type
Academic Journal
Source
Infection and Drug Resistance. December 31, 2021, Vol. 14, p5199, 10 p.
Subject
Nucleotide sequencing -- Analysis -- Health aspects
DNA sequencing -- Analysis -- Health aspects
Hepatitis C virus -- Health aspects -- Analysis
Phylogeny -- Health aspects -- Analysis
Liver -- Analysis -- Health aspects
Hepatitis C -- Care and treatment
Hepatoma -- Care and treatment
Language
English
ISSN
1178-6973
Abstract
Background: The present paper evaluates the genetic variability of HCV in patients with hepatocellular carcinoma (HCC). Methods: Amino acid substitutions (aas) in NS3, NS5A and core regions were analyzed in 17 patients with HCC (Cases) and 13 without HCC (Controls), all naive to DAAs. For the Cases, a sample of neoplastic liver tissue, non-neoplastic liver tissue and a serum sample were collected; for the Controls, a sample of liver tissue was collected. Sanger sequencing of three regions was performed using homemade protocols. Results: Phylogenetic trees showed that there was no difference in the virus populations in the three compartments analyzed for the three HCV regions in patients with HCC. Low variability and no difference between the Cases and Controls were observed in the core and NS5A regions; however, in the NS3 region, a higher variability was observed in the Cases. No difference was observed in the core region between Cases and Controls. In NS3, aa substitutions at positions 103 and 122 were more frequently found in Cases than Controls (in both cases 50% vs 9.1%, p Conclusion: These data may suggest a higher aa variability in patients with HCC than in those without, especially in the NS3 region. Keywords: hepatocellular carcinoma, HCV, viral variability, chronic hepatitis C, chronic infection C, core region, NS5A region, NS3 region, aa substitutions, phylogenesis
Introduction Hepatocellular carcinoma (HCC) is the sixth most frequent cancer worldwide and the fourth leading cause of cancer-related deaths and arises especially in cirrhotic patients. (1) The prevalence of HCC [...]